Therefore, specific identification of AARS1/2 expression and lactylation-related function across different tissues and cancer types is essential to offer novel, context-dependent therapeutic targets for cancer and other diseases driven by AARS1/2 dysregulation. The gene discussed is AARS1; the disease is cancer.